Iwamoto, Fabio M <br/><br/>
Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas.  [electronic resource] 

 -  Cancer  Apr 2010 
 - 1776-82 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.24957  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Benzodiazepines--therapeutic use<br/>Brain Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Drug Evaluation<br/>Female<br/>Glioma--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Receptors, AMPA--antagonists & inhibitors